Orchard Therapeutics plc Annual Operating Income (Loss) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Orchard Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2022.
  • Orchard Therapeutics plc Operating Income (Loss) for the quarter ending September 30, 2023 was -$21.6M, a 15.2% increase year-over-year.
  • Orchard Therapeutics plc Operating Income (Loss) for the twelve months ending September 30, 2023 was -$102M, a 22.7% increase year-over-year.
  • Orchard Therapeutics plc annual Operating Income (Loss) for 2022 was -$127M, a 9.5% increase from 2021.
  • Orchard Therapeutics plc annual Operating Income (Loss) for 2021 was -$140M, a 10.5% increase from 2020.
  • Orchard Therapeutics plc annual Operating Income (Loss) for 2020 was -$157M, a 9.2% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$127M +$13.3M +9.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 -$140M +$16.5M +10.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$157M +$15.9M +9.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$173M +$62.2M +26.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$235M -$197M -510% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$38.5M -$19.3M -101% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$19.2M Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.